反応式
[CH3:1][N:2]1[C:7]([CH3:9])([CH3:8])[CH2:6][C:5](=[N:10][OH:11])[CH2:4][C:3]1([CH3:13])[CH3:12].C([O-])(=O)C.C([O-])(=O)C.C([O-])(=O)C.C([O-])(=O)C.[Pb+4].[CH3:31][C:32]([CH3:37])([CH3:36])[C:33]([OH:35])=[O:34]>>[C:33]([O:35][C:5]1([N:10]=[O:11])[CH2:6][C:7]([CH3:9])([CH3:8])[N:2]([CH3:1])[C:3]([CH3:13])([CH3:12])[CH2:4]1)(=[O:34])[C:32]([CH3:37])([CH3:36])[CH3:31]参加物
4
実験手順
1,2,2,6,6-Pentamethyl-4-nitrosopiperidin-4-yl pivalate was prepared from 1,2,2,6,6-pentamethyl-piperidin-4-one oxime, lead tetraacetate and trimethylacetic acid using conditions of General Method 3. 1H NMR (250 MHz, CHLOROFORM-d) δ 2.43-2.64 (5H, m), 2.09 (3H, s), 1.91 (2H, d, 14.2 Hz), 1.39 (6H, d, 5.9 Hz), 1.30 (9H, s), 1.25 (6H, d, 2.6 Hz).
出典と根拠
- ORDレコード
- ord-c47e4a33ebf44f39b0ce4364c49f4b18
- 出典データセット
- uspto-grants-2012_11
- 特許番号
- US08318705B2
関連ノート
読み込み中…